Endurant Capital Management LP Decreases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Endurant Capital Management LP decreased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 42.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,357 shares of the biotechnology company’s stock after selling 61,017 shares during the period. BioMarin Pharmaceutical comprises about […]

Related Keywords

Johnc Klock ,Stifel Nicolaus ,V Bryan Lawlis ,Jean Jacques Bienaime ,Group Wealth Management ,Nasdaq ,Acadian Asset Management ,Grey Fox Wealth Advisors ,Altshuler Shaham Ltd ,Citigroup ,Wealth Advisors Inc ,Exchange Commission ,Biomarin Pharmaceutical Inc ,Securities Exchange Commission ,Endurant Capital Management ,Biomarin Pharmaceutical ,Get Rating ,Marin Pharmaceutical ,Capital Management ,Shaham Ltd ,Fox Wealth Advisors ,Wealth Management ,Asset Management ,Jacques Bienaime ,Directorv Bryan Lawlis ,Visit Holdingschannel ,Biomarin Pharmaceutical Daily ,Nasdaq Bmrn ,Bmrn ,Medical ,09061g10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,